Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Heat shock proteins 60 and 70 are associated with long-term outcome of T1-stage high-grade urothelial tumors of the bladder treated with intravesical Bacillus Calmette-Guérin immunotherapy.

Mano R, Zilber S, Di Natale RG, Kedar D, Lifshitz DA, Yossepowitch O, Baniel J, Margel D.

Urol Oncol. 2018 Oct 15. pii: S1078-1439(18)30348-X. doi: 10.1016/j.urolonc.2018.09.007. [Epub ahead of print]

PMID:
30337218
2.

Predictors of surgical site infection after radical cystectomy: should we enhance surgical antibiotic prophylaxis?

Goldberg H, Shenhar C, Tamir H, Mano R, Baniel J, Margel D, Kedar D, Lifshitz D, Yossepowitch O.

World J Urol. 2018 Sep 15. doi: 10.1007/s00345-018-2482-5. [Epub ahead of print]

PMID:
30220044
3.

Predictors of oncological outcomes in T1G3 patients treated with BCG who undergo radical cystectomy.

Soria F, Pisano F, Gontero P, Palou J, Joniau S, Serretta V, Larré S, Di Stasi S, van Rhijn B, Witjes JA, Grotenhuis A, Colombo R, Briganti A, Babjuk M, Soukup V, Malmstrom PU, Irani J, Malats N, Baniel J, Mano R, Cai T, Cha E, Ardelt P, Varkarakis J, Bartoletti R, Dalbagni G, Shariat SF, Xylinas E, Karnes RJ, Sylvester R.

World J Urol. 2018 Nov;36(11):1775-1781. doi: 10.1007/s00345-018-2450-0. Epub 2018 Aug 31.

PMID:
30171454
4.

Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought.

Palou J, Pisano F, Sylvester R, Joniau S, Serretta V, Larré S, Di Stasi S, van Rhijn B, Witjes AJ, Grotenhuis A, Colombo R, Briganti A, Babjuk M, Soukup V, Malmstrom PU, Irani J, Malats N, Baniel J, Mano R, Cai T, Cha EK, Ardelt P, Varkarakis J, Bartoletti R, Dalbagni G, Shariat SF, Xylinas E, Karnes RJ, Gontero P.

World J Urol. 2018 Oct;36(10):1621-1627. doi: 10.1007/s00345-018-2299-2. Epub 2018 May 2.

PMID:
29721611
5.

Malignant Abnormalities in Male BRCA Mutation Carriers: Results From a Prospectively Screened Cohort.

Mano R, Tamir S, Kedar I, Benjaminov O, Baniel J, Tabachnik T, Margel D.

JAMA Oncol. 2018 Jun 1;4(6):872-874. doi: 10.1001/jamaoncol.2018.0271. No abstract available.

PMID:
29710070
6.

Stone culture in patients undergoing percutaneous nephrolithotomy: a practical point of view.

Nevo A, Mano R, Shoshani O, Kriderman G, Schreter E, Lifshitz D.

Can J Urol. 2018 Apr;25(2):9238-9244.

PMID:
29680000
7.

Urinary Tract Infections After Urinary Diversion-Different Occurrence Patterns in Patients With Ileal Conduit and Orthotopic Neobladder.

Mano R, Goldberg H, Stabholz Y, Hazan D, Margel D, Kedar D, Baniel J, Yossepowitch O.

Urology. 2018 Jun;116:87-92. doi: 10.1016/j.urology.2018.03.042. Epub 2018 Apr 4.

PMID:
29626568
8.

Reply by the Authors.

Halstuch D, Ehrlich Y, Shenhar C, Mano R, Baniel J, Margel D, Lifshitz DA.

Urology. 2018 May;115:193. doi: 10.1016/j.urology.2018.02.006. Epub 2018 Mar 28. No abstract available.

PMID:
29477312
9.

Is there a difference in testosterone levels and its regulators in men carrying BRCA mutations?

Goldberg H, Grievink LS, Mano R, Ber Y, Ozalbo R, Tuval S, Baniel J, Margel D.

Oncotarget. 2017 Oct 10;8(61):103843-103850. doi: 10.18632/oncotarget.21802. eCollection 2017 Nov 28.

10.

Transplant Kidney Retrograde Ureteral Stent Placement and Exchange: Overcoming the Challenge.

Halstuch D, Ehrlich Y, Shenhar C, Mano R, Baniel J, Margel D, Lifshitz DA.

Urology. 2018 Jan;111:220-224. doi: 10.1016/j.urology.2017.09.012. Epub 2017 Sep 28.

PMID:
28965862
11.

Synthesis, Antimicrobial, and Antioxidant Activities of Chalcogen-Containing Nitrone Derivatives from (R)-citronellal.

Ferraz MC, Mano RA, Oliveira DH, Maia DSV, Silva WP, Savegnago L, Lenardão EJ, Jacob RG.

Medicines (Basel). 2017 Jun 10;4(2). pii: E39. doi: 10.3390/medicines4020039.

12.

Lower Urinary Tract Symptoms and Benign Prostate Hyperplasia Features Among Male BRCA Mutation Carriers.

Goldberg H, Grievink LS, Mano R, Ber Y, Ozalbo R, Tuval S, Baniel J, Margel D.

Urology. 2017 Oct;108:71-75. doi: 10.1016/j.urology.2017.05.036. Epub 2017 May 31.

PMID:
28577930
13.

Post-ritual Circumcision Bleeding-Characteristics and Treatment Outcome.

Mano R, Nevo A, Sivan B, Morag R, Ben-Meir D.

Urology. 2017 Jul;105:157-162. doi: 10.1016/j.urology.2017.03.038. Epub 2017 Apr 4.

PMID:
28389263
14.

Ureteric stent dwelling time: a risk factor for post-ureteroscopy sepsis.

Nevo A, Mano R, Baniel J, Lifshitz DA.

BJU Int. 2017 Jul;120(1):117-122. doi: 10.1111/bju.13796. Epub 2017 Feb 22.

15.

Clinical Implications of Stent Culture in Patients with Indwelling Ureteral Stents Prior to Ureteroscopy.

Nevo A, Mano R, Schreter E, Lifshitz DA.

J Urol. 2017 Jul;198(1):116-121. doi: 10.1016/j.juro.2017.01.064. Epub 2017 Jan 26.

PMID:
28132770
16.

Missed Torsion of the Spermatic Cord: A Common yet Underreported Event.

Nevo A, Mano R, Sivan B, Ben-Meir D.

Urology. 2017 Apr;102:202-206. doi: 10.1016/j.urology.2016.12.041. Epub 2016 Dec 29.

PMID:
28042047
17.

Surgical Treatment of Tumors Involving Kidneys With Fusion Anomalies: A Contemporary Series.

Mano R, Hakimi AA, Sankin AI, Sternberg IA, Chevinsky MS, Russo P.

Urology. 2016 Dec;98:97-102. doi: 10.1016/j.urology.2016.07.034. Epub 2016 Aug 3.

18.

Clinical Outcome of Patients with Fibrosis/Necrosis at Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Advanced Germ Cell Tumors.

Mano R, Becerra MF, Carver BS, Bosl GJ, Motzer RJ, Bajorin DF, Feldman DR, Sheinfeld J.

J Urol. 2017 Feb;197(2):391-397. doi: 10.1016/j.juro.2016.09.113. Epub 2016 Oct 5.

19.

The very-high-risk prostate cancer: a contemporary update.

Mano R, Eastham J, Yossepowitch O.

Prostate Cancer Prostatic Dis. 2016 Dec;19(4):340-348. doi: 10.1038/pcan.2016.40. Epub 2016 Sep 13. Review.

20.

Impact of Ureteroscopy Before Nephroureterectomy for Upper Tract Urothelial Carcinoma on Oncologic Outcomes.

Sankin A, Tin AL, Mano R, Chevinsky M, Jakubowski C, Sfakianos JP, Cha EK, Yee A, Friedman FM, Sjoberg DD, Ehdaie B, Coleman J.

Urology. 2016 Aug;94:148-53. doi: 10.1016/j.urology.2016.05.039. Epub 2016 May 26.

21.

The effect of delaying nephrectomy on oncologic outcomes in patients with renal tumors greater than 4cm.

Mano R, Vertosick EA, Hakimi AA, Sternberg IA, Sjoberg DD, Bernstein M, Dalbagni G, Coleman JA, Russo P.

Urol Oncol. 2016 May;34(5):239.e1-8. doi: 10.1016/j.urolonc.2015.12.001. Epub 2016 Jan 12.

22.

Orthotopic neobladder vs. ileal conduit urinary diversion: A long-term quality-of-life comparison.

Goldberg H, Baniel J, Mano R, Rotlevy G, Kedar D, Yossepowitch O.

Urol Oncol. 2016 Mar;34(3):121.e1-7. doi: 10.1016/j.urolonc.2015.10.006. Epub 2015 Dec 3.

PMID:
26670201
23.

Validation and genomic interrogation of the MET variant rs11762213 as a predictor of adverse outcomes in clear cell renal cell carcinoma.

Hakimi AA, Ostrovnaya I, Jacobsen A, Susztak K, Coleman JA, Russo P, Winer AG, Mano R, Sankin AI, Motzer RJ, Voss MH, Offit K, Purdue M, Pomerantz M, Freedman M, Choueiri TK, Hsieh JJ, Klein RJ.

Cancer. 2016 Feb 1;122(3):402-10. doi: 10.1002/cncr.29765. Epub 2015 Oct 27.

24.

The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade/Grade 3 bladder cancer treated with bacille Calmette-Guérin.

Gontero P, Sylvester R, Pisano F, Joniau S, Oderda M, Serretta V, Larré S, Di Stasi S, Van Rhijn B, Witjes AJ, Grotenhuis AJ, Colombo R, Briganti A, Babjuk M, Soukup V, Malmström PU, Irani J, Malats N, Baniel J, Mano R, Cai T, Cha EK, Ardelt P, Vakarakis J, Bartoletti R, Dalbagni G, Shariat SF, Xylinas E, Karnes RJ, Palou J.

BJU Int. 2016 Jul;118(1):44-52. doi: 10.1111/bju.13354. Epub 2015 Nov 6.

25.

Prognostic Model for Predicting Survival in Patients with Disease Recurrence Following Radical Cystectomy.

Kluth LA, Xylinas E, Rieken M, Kent M, Ikeda M, Matsumoto K, Hagiwara M, Kikuchi E, Bing MT, Gupta A, Sewell JM, Konety BR, Todenhöfer T, Schwentner C, Masson-Lecomte A, Vordos D, Roghmann F, Noldus J, Razmaria AA, Smith ND, Comploj E, Pycha A, Rink M, Baniel J, Mano R, Novara G, Aziz A, Fritsche HM, Brisuda A, Bivalacqua T, Gontero P, Boorjian SA, Vickers AJ, Shariat SF.

Eur Urol Focus. 2015 Aug;1(1):75-81. doi: 10.1016/j.euf.2014.10.003. Epub 2015 May 28.

PMID:
28723361
26.

Can renal hemangiomas be diagnosed preoperatively?

Sternberg IA, Katz BF, Baldinger L, Mano R, Paz GE, Bernstein M, Akin O, Russo P, Karlo C.

Isr Med Assoc J. 2015 Mar;17(3):157-60.

27.

Partial and Radical Nephrectomy for Unilateral Synchronous Multifocal Renal Cortical Tumors.

Mano R, Kent M, Larish Y, Winer AG, Chevinsky MS, Hakimi AA, Sternberg IA, Sjoberg DD, Russo P.

Urology. 2015 Jun;85(6):1404-10. doi: 10.1016/j.urology.2015.02.032. Epub 2015 Apr 11.

28.

TCEB1-mutated renal cell carcinoma: a distinct genomic and morphological subtype.

Hakimi AA, Tickoo SK, Jacobsen A, Sarungbam J, Sfakianos JP, Sato Y, Morikawa T, Kume H, Fukayama M, Homma Y, Chen YB, Sankin A, Mano R, Coleman JA, Russo P, Ogawa S, Sander C, Hsieh JJ, Reuter VE.

Mod Pathol. 2015 Jun;28(6):845-853. doi: 10.1038/modpathol.2015.6. Epub 2015 Feb 13.

29.

Pathological Stage T3a Significantly Increases Disease Recurrence across All Tumor Sizes in Renal Cell Carcinoma.

Chevinsky M, Imnadze M, Sankin A, Winer A, Mano R, Jakubowski C, Mashni J, Sjoberg DD, Chen YB, Tickoo SK, Reuter VE, Hakimi AA, Russo P.

J Urol. 2015 Aug;194(2):310-5. doi: 10.1016/j.juro.2015.02.013. Epub 2015 Feb 9.

30.

Cost comparison of open and robotic partial nephrectomy using a short postoperative pathway.

Mano R, Schulman A, Hakimi AA, Sternberg IA, Bernstein M, Bochner BH, Coleman JA, Russo P.

Urology. 2015 Mar;85(3):596-603. doi: 10.1016/j.urology.2014.10.044. Epub 2015 Jan 10.

PMID:
25586478
31.

Reply: To PMID 25586475.

Mano R, Russo P.

Urology. 2015 Mar;85(3):603-4. doi: 10.1016/j.urology.2014.10.046. Epub 2015 Jan 10. No abstract available.

PMID:
25586474
32.

Urinary retention in children.

Nevo A, Mano R, Livne PM, Sivan B, Ben-Meir D.

Urology. 2014 Dec;84(6):1475-9. doi: 10.1016/j.urology.2014.08.020. Epub 2014 Oct 14.

PMID:
25440826
33.

Association between visceral and subcutaneous adiposity and clinicopathological outcomes in non-metastatic clear cell renal cell carcinoma.

Mano R, Hakimi AA, Zabor EC, Bury MA, Donati OF, Karlo CA, Bazzi WM, Furberg H, Russo P.

Can Urol Assoc J. 2014 Sep;8(9-10):E675-80. doi: 10.5489/cuaj.1979.

34.

Subcentimeter pulmonary nodules are not associated with disease progression in patients with renal cell carcinoma.

Mano R, Vertosick E, Sankin AI, Chevinsky MS, Larish Y, Jakubowski CD, Hötker AM, Hakimi AA, Sjoberg DD, Akin O, Russo P.

J Urol. 2015 Mar;193(3):776-82. doi: 10.1016/j.juro.2014.09.020. Epub 2014 Sep 18.

35.

Open mini-flank partial nephrectomy: an essential contemporary operation.

Russo P, Mano R.

Korean J Urol. 2014 Sep;55(9):557-67. doi: 10.4111/kju.2014.55.9.557. Epub 2014 Sep 5.

36.

The impact of genetic heterogeneity on biomarker development in kidney cancer assessed by multiregional sampling.

Sankin A, Hakimi AA, Mikkilineni N, Ostrovnaya I, Silk MT, Liang Y, Mano R, Chevinsky M, Motzer RJ, Solomon SB, Cheng EH, Durack JC, Coleman JA, Russo P, Hsieh JJ.

Cancer Med. 2014 Dec;3(6):1485-92. doi: 10.1002/cam4.293. Epub 2014 Aug 14.

37.

In vitro and in vivo acaricide action of juvenoid analogs produced from the chemical modification of Cymbopogon spp. and Corymbia citriodora essential oil on the cattle tick Rhipicephalus (Boophilus) microplus.

Chagas AC, Domingues LF, Fantatto RR, Giglioti R, Oliveira MC, Oliveira DH, Mano RA, Jacob RG.

Vet Parasitol. 2014 Sep 15;205(1-2):277-84. doi: 10.1016/j.vetpar.2014.06.030. Epub 2014 Jul 8.

PMID:
25085774
38.

Neutrophil-to-lymphocyte ratio predicts progression and recurrence of non-muscle-invasive bladder cancer.

Mano R, Baniel J, Shoshany O, Margel D, Bar-On T, Nativ O, Rubinstein J, Halachmi S.

Urol Oncol. 2015 Feb;33(2):67.e1-7. doi: 10.1016/j.urolonc.2014.06.010. Epub 2014 Jul 21.

PMID:
25060672
39.

Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Guérin: results of a retrospective multicenter study of 2451 patients.

Gontero P, Sylvester R, Pisano F, Joniau S, Vander Eeckt K, Serretta V, Larré S, Di Stasi S, Van Rhijn B, Witjes AJ, Grotenhuis AJ, Kiemeney LA, Colombo R, Briganti A, Babjuk M, Malmström PU, Oderda M, Irani J, Malats N, Baniel J, Mano R, Cai T, Cha EK, Ardelt P, Varkarakis J, Bartoletti R, Spahn M, Johansson R, Frea B, Soukup V, Xylinas E, Dalbagni G, Karnes RJ, Shariat SF, Palou J.

Eur Urol. 2015 Jan;67(1):74-82. doi: 10.1016/j.eururo.2014.06.040. Epub 2014 Jul 16.

PMID:
25043942
40.

Online health information, situational effects and health changes among e-patients in Israel: A 'push/pull' perspective.

Mano R.

Health Expect. 2015 Dec;18(6):2489-500. doi: 10.1111/hex.12218. Epub 2014 Jun 17.

41.

Outcomes in patients undergoing nephrectomy for renal cancer on chronic anticoagulation therapy.

Sfakianos JP, Hakimi AA, Kim PH, Zabor EC, Mano R, Bernstein M, Karellas M, Russo P.

Eur J Surg Oncol. 2014 Dec;40(12):1700-5. doi: 10.1016/j.ejso.2014.04.010. Epub 2014 Apr 24.

43.

Impact of recurrent copy number alterations and cancer gene mutations on the predictive accuracy of prognostic models in clear cell renal cell carcinoma.

Hakimi AA, Mano R, Ciriello G, Gonen M, Mikkilineni N, Sfakianos JP, Kim PH, Motzer RJ, Russo P, Reuter VE, Hsieh JJ, Ostrovnaya I.

J Urol. 2014 Jul;192(1):24-9. doi: 10.1016/j.juro.2014.01.088. Epub 2014 Feb 8.

44.

Low-dose oral desmopressin for treatment of nocturia and nocturnal enuresis in patients after radical cystectomy and orthotopic urinary diversion.

Goldberg H, Baniel J, Mano R, Gillon G, Kedar D, Yossepowitch O.

BJU Int. 2014 Nov;114(5):727-32. doi: 10.1111/bju.12598. Epub 2014 Jul 27.

45.

Urinary tract infections in patients with orthotopic neobladder.

Mano R, Baniel J, Goldberg H, Stabholz Y, Kedar D, Yossepowitch O.

Urol Oncol. 2014 Jan;32(1):50.e9-14. doi: 10.1016/j.urolonc.2013.07.017. Epub 2013 Nov 13.

PMID:
24239471
46.

Testicular torsion in the first year of life--characteristics and treatment outcome.

Mano R, Livne PM, Nevo A, Sivan B, Ben-Meir D.

Urology. 2013 Nov;82(5):1132-7. doi: 10.1016/j.urology.2013.07.018. Epub 2013 Aug 31.

PMID:
24001706
47.

Presence of detrusor muscle in bladder tumor specimens--predictors and effect on outcome as a measure of resection quality.

Shoshany O, Mano R, Margel D, Baniel J, Yossepowitch O.

Urol Oncol. 2014 Jan;32(1):40.e17-22. doi: 10.1016/j.urolonc.2013.04.009. Epub 2013 Aug 2.

PMID:
23911682
48.

Viability of smallholder dairying in Wedza, Zimbabwe.

Zvinorova PI, Halimani TE, Mano RT, Ngongoni NT.

Trop Anim Health Prod. 2013 Apr;45(4):1007-15. doi: 10.1007/s11250-012-0325-8. Epub 2012 Dec 5.

PMID:
23212836
49.

Resection of ureteral orifice during transurethral resection of bladder tumor: functional and oncologic implications.

Mano R, Shoshany O, Baniel J, Yossepowitch O.

J Urol. 2012 Dec;188(6):2129-33. doi: 10.1016/j.juro.2012.08.006. Epub 2012 Oct 18.

PMID:
23083866
50.

Predictors of cancer-specific mortality after disease recurrence following radical cystectomy.

Rink M, Lee DJ, Kent M, Xylinas E, Fritsche HM, Babjuk M, Brisuda A, Hansen J, Green DA, Aziz A, Cha EK, Novara G, Chun FK, Lotan Y, Bastian PJ, Tilki D, Gontero P, Pycha A, Baniel J, Mano R, Ficarra V, Trinh QD, Tagawa ST, Karakiewicz PI, Scherr DS, Sjoberg DD, Shariat SF; Bladder Cancer Research Consortium.

BJU Int. 2013 Mar;111(3 Pt B):E30-6. doi: 10.1111/j.1464-410X.2012.11433.x. Epub 2012 Sep 3.

Supplemental Content

Support Center